A Rare Case of an Immunocompetent Patient With Isolated Pulmonary Mucormycosis
As one of the most lethal infections caused by fungi, pulmonary mucormycosis usually affects patients who are immunocompromised. Isolated pulmonary mucormycosis in immunocompetent patients is very rare.This report describes a 65-year-old immunocompetent ...
Mohammad Rezaei Zadeh Rukerd +2 more
exaly +3 more sources
Comparative Prognosis of Fungal Balls Versus Invasive Pulmonary Mucormycosis [PDF]
Jiayu Wang,1– 4 Naishu Xie,1– 4 Rui Zhao,1– 4 Huihui Zeng,1– 4 Yan Chen1– 4 1Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People’s Republic of China; 2Research Unit of ...
Wang J, Xie N, Zhao R, Zeng H, Chen Y
doaj +2 more sources
Invasive Pulmonary Mucormycosis and Aspergillosis in a Patient With Decompensated Hepatic Cirrhosis
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in non-cirrhotic patients with diabetes mellitus, neutropenia, or treatment with corticosteroids.
Scott G Filler, Tam T Van
exaly +3 more sources
Pulmonary Aspergillosis and Mucormycosis in a Patient With COVID-19
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids.
Jon Persichino, Andre Johnson
exaly +3 more sources
Plasma microbial cell-free DNA testing for early diagnosis of pulmonary mucormycosis in a kidney transplant recipient [PDF]
Pulmonary mucormycosis is one of the most lethal invasive fungal infections encountered in solid organ transplant recipients, with mortality rates ranging from 43% to 73%.
Blake Piepenbrink +4 more
doaj +2 more sources
Transcriptomic and proteomic profiling of pulmonary mucormycosis reveals a failed activation of host immune response [PDF]
IntroductionMucormycosis is one of the most life-threatening fungal infections with delayed diagnosis and limited antifungal treatments. The transcriptome and proteome of pulmonary mucormycosis have not been fully investigated.MethodsWe obtained lung ...
Jinjin Zhong +10 more
doaj +2 more sources
A patient with well-controlled type 2 diabetes mellitus developed a severe pulmonary infection secondary to Rhizopus spp. after receiving short courses of corticosteroids for a respiratory tract infection.
Kathy Hoang +2 more
exaly +3 more sources
Diagnosis, clinical features, and mortality risk factors in a Chinese cohort with pulmonary mucormycosis. [PDF]
BackgroundPulmonary mucormycosis is a rare and often fatal fungal infection. Identifying high-risk factors for pulmonary mucormycosis holds the potential to improve patient outcomes.
Junjun Wan +3 more
doaj +2 more sources
Prevalence, predictors and outcome of pulmonary mucormycosis in COVID-19 associated rhino orbital mucormycosis in a tertiary care centre in south India [PDF]
Background and Purpose: India witnessed an explosive rise in mucormycosis following COVID-19 infection. While rhino orbital mucormycosis was the most common presentation, pulmonary mucormycosis was closely followed.
Karthigeyan Thanjavur Sethuraman +3 more
doaj +1 more source
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
Background Mucormycosis is a rare fungal infection occurring chiefly in the lung or the rhino-orbital-cerebral compartment, particularly in patients with immunodeficiency or diabetes mellitus. Among Mucorales fungi, Rhizopus spp.
F. Yuan +5 more
doaj +1 more source

